Bengaluru, March 1 (IANS) The global oncology sector has witnessed a funding of $424 million to date this year, as the dynamic landscape of the sector in India unveils a compelling narrative of innovation and funding trends amid advancements in new-age technologies, a report showed on Friday.
In India, 94 companies have been established so far in the sector, with 55 of them successfully securing funding.
Perfint Healthcare in the country emerged as a frontrunner, securing $40.1 million in total funding, leading a trail that includes Immuneel and Zumutor with $27.4 million and $26.2 million, respectively.
A groundbreaking revelation is the dominance of the Oncology drugs, securing $27.1 million, with significant contributions from key players like ImmunoACT and Immuneel, according to the report by market intelligence firm Tracxn.
Bengaluru takes the lead with the highest number of founded companies (20) in the oncology sector.
“With over 5,500 companies worldwide and approximately 4,000 funded to date, the sector is at the forefront of redefining cancer treatment methodologies through advancements in AI, robotics and genomic sequencing,” according to the report.
The overall funding for 2023 amounted to $9.2 billion. This sector has witnessed the emergence of 12 unicorn companies to date.
“Top investors like Orbimed, EIC Fund, and RA Capital Management are pivotal in driving the Oncology sector. In the last two years, Y Combinator, Alexandria, and Proxima Ventures emerged as top seed investors, while Orbimed, Alexandria, and RA Capital Management took the lead in early-stage investments,” it added.
–IANS
na/dpb
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
